Sutro Biopharma, Inc.
STRO · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $190 | $69 | $47 | $30 |
| Short-Term Investments | $127 | $306 | $287 | $168 |
| Receivables | $9 | $36 | $7 | $12 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $18 | $10 | $12 | $8 |
| Total Curr. Assets | $343 | $422 | $353 | $219 |
| Property Plant & Equip (Net) | $36 | $45 | $51 | $52 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | -$32 | $69 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $8 | $4 | $35 | $3 |
| Total NC Assets | $44 | $49 | $54 | $123 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $387 | $471 | $407 | $341 |
| Liabilities | – | – | – | – |
| Payables | $10 | $9 | $5 | $6 |
| Short-Term Debt | $7 | $10 | $22 | $10 |
| Tax Payable | $0 | $15 | $0 | $0 |
| Deferred Revenue | $70 | $21 | $17 | $5 |
| Other Curr. Liab. | $44 | $38 | $23 | $20 |
| Total Curr. Liab. | $132 | $94 | $67 | $42 |
| LT Debt | $16 | $23 | $33 | $47 |
| Deferred Rev, NC | $193 | $202 | $90 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $2 | $2 | $0 | $0 |
| Total NC Liab. | $211 | $227 | $123 | $47 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $23 | $30 | $34 | $32 |
| Total Liabilities | $343 | $321 | $190 | $89 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$787 | -$559 | -$453 | -$333 |
| AOCI | $0 | $0 | -$1 | -$0 |
| Other Equity | $831 | $709 | $670 | $586 |
| Total Equity | $45 | $150 | $217 | $253 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $387 | $471 | $407 | $341 |
| Net Debt | -$167 | -$36 | $8 | $27 |